Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma

Hepatology Research

Volumn 42, Issue 10, 2012, Pages 990-998

  van Malenstein, Hannah ^a   Komuta, Mina ^b   Verslype, Chris ^a   Vandecaveye, Vincent ^b   Van Calster, Ben ^a,b   Topal, Baki ^c   Laleman, Wim ^a   Cassiman, David ^a   Van Steenbergen, Werner ^a   Aerts, Raymond ^c   Vanbeckevoort, Dirk ^b   Bielen, Didier ^b   Pirenne, Jacques ^c   van Pelt, Jos ^a   Roskams, Tania ^b   Nevens, Frederik ^a  

^a United Arab Emirates   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Hepatocellular carcinoma; Histology; Keratin 19; Needle biopsy; Prognosis

Indexed keywords

ALPHA FETOPROTEIN; CYTOKERATIN 19; EPITHELIAL CELL ADHESION MOLECULE; SORAFENIB;

ADULT; AGED; ARTICLE; ASCITES; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; DISTANT METASTASIS; END STAGE LIVER DISEASE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER HISTOLOGY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; OVERALL SURVIVAL; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME;

EID: 84866774340     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01010.x     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2010; 53: 1020-2.
3. Omata M, Lesmana LA, Tateishi R etal. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-74.
4. Clinical Practice Guidelines for Hepatocellular Carcinoma - The Japan Society of Hepatology 2009 update. Hepatol Res 2010; 40 (Suppl 1): 2-144.
5. Llovet JM, Di Bisceglie AM, Bruix J etal. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 698-711.
6. Jonas S, Bechstein WO, Steinmuller T etal. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-6.
7. Tamura S, Kato T, Berho M etal. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136: 25-30; discussion 1.
8. Kaihara S, Kiuchi T, Ueda M etal. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 2003; 75: S37-40.
9. Zavaglia C, De Carlis L, Alberti AB etal. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005; 100: 2708-16.
10. Silva M, Moya A, Berenguer M etal. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 2008; 14: 1449-60.
11. Durnez A, Verslype C, Nevens F etal. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006; 49: 138-51.
12. Yang XR, Xu Y, Shi GM etal. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection. Clin Cancer Res 2008; 14: 3850-9.
13. Yamashita T, Ji J, Budhu A etal. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136: 1012-24.
14. Uenishi T, Kubo S, Yamamoto T etal. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 2003; 94: 851-7.
15. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008; 57: 1592-6.
16. Colecchia A, Scaioli E, Montrone L etal. Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. J Hepatol 2011; 54: 300-5.
17. Verslype C, Van Cutsem E, Dicato M etal. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol 2009; 20 (Suppl 7): vii1-vii6.
18. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
19. ICGHN. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49: 658-64.
20. Zhuang PY, Zhang JB, Zhu XD etal. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 2008; 112: 2740-8.
21. Tsuchiya K, Komuta M, Yasui Y etal. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation. Oncology 2011; 80: 278-88.
22. Farinati F, Marino D, De Giorgio M etal. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 2006; 101: 524-32.
23. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996; 17: 343-6.
24. Harrell FE Jr. Regression Modelling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer, 2001.
25. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York: Springer, 2009.
26. Roskams T, Yang SQ, Koteish A etal. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163: 1301-11.
27. Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989; 134: 1347-63.
28. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25: 3818-22.
29. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228: 479-90.
30. Shah SA, Cleary SP, Wei AC etal. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007; 141: 330-9.
31. D'Amico F, Schwartz M, Vitale A etal. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl 2009; 15: 1278-87.
32. DuBay D, Sandroussi C, Sandhu L etal. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg 2011; 253: 166-72.
33. Kim H, Choi GH, Na DC etal. Human hepatocellular carcinomas with "stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology 2011; 54: 1707-17.
34. Villanueva A, Hoshida Y, Battiston C etal. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011; 140: 1501-12, e2.